These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 11717332)
1. Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol. Song RX; Mor G; Naftolin F; McPherson RA; Song J; Zhang Z; Yue W; Wang J; Santen RJ J Natl Cancer Inst; 2001 Nov; 93(22):1714-23. PubMed ID: 11717332 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER(+) breast cancer cells. Song RX; Zhang Z; Mor G; Santen RJ Apoptosis; 2005 May; 10(3):667-78. PubMed ID: 15909128 [TBL] [Abstract][Full Text] [Related]
3. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. Lewis JS; Meeke K; Osipo C; Ross EA; Kidawi N; Li T; Bell E; Chandel NS; Jordan VC J Natl Cancer Inst; 2005 Dec; 97(23):1746-59. PubMed ID: 16333030 [TBL] [Abstract][Full Text] [Related]
4. Adenosine monophosphate activated protein kinase (AMPK), a mediator of estradiol-induced apoptosis in long-term estrogen deprived breast cancer cells. Chen H; Wang JP; Santen RJ; Yue W Apoptosis; 2015 Jun; 20(6):821-30. PubMed ID: 25721362 [TBL] [Abstract][Full Text] [Related]
5. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation. Chan CM; Martin LA; Johnston SR; Ali S; Dowsett M J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723 [TBL] [Abstract][Full Text] [Related]
6. Metalloestrogenic effects of cadmium are absent in long-term estrogen-deprived MCF-7 cells: Evidence for the involvement of constitutively activated estrogen receptor α and very low expression of G protein-coupled estrogen receptor 1. Hirao-Suzuki M; Takeda S; Kodama Y; Takiguchi M; Toda A; Ohara M Toxicol Lett; 2020 Feb; 319():22-30. PubMed ID: 31689473 [TBL] [Abstract][Full Text] [Related]
7. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis. Lewis-Wambi JS; Kim HR; Wambi C; Patel R; Pyle JR; Klein-Szanto AJ; Jordan VC Breast Cancer Res; 2008; 10(6):R104. PubMed ID: 19061505 [TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Jeng MH; Shupnik MA; Bender TP; Westin EH; Bandyopadhyay D; Kumar R; Masamura S; Santen RJ Endocrinology; 1998 Oct; 139(10):4164-74. PubMed ID: 9751496 [TBL] [Abstract][Full Text] [Related]
9. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease. Starcevic SL; Elferink C; Novak RF J Natl Cancer Inst; 2001 May; 93(10):776-82. PubMed ID: 11353788 [TBL] [Abstract][Full Text] [Related]
10. Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer. Osipo C; Gajdos C; Liu H; Chen B; Jordan VC J Natl Cancer Inst; 2003 Nov; 95(21):1597-608. PubMed ID: 14600092 [TBL] [Abstract][Full Text] [Related]
11. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. Mor G; Sapi E; Abrahams VM; Rutherford T; Song J; Hao XY; Muzaffar S; Kohen F J Immunol; 2003 Jan; 170(1):114-22. PubMed ID: 12496390 [TBL] [Abstract][Full Text] [Related]
12. Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells. Jeng MH; Yue W; Eischeid A; Wang JP; Santen RJ Breast Cancer Res Treat; 2000 Aug; 62(3):167-75. PubMed ID: 11072781 [TBL] [Abstract][Full Text] [Related]
13. Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotropes. Jaita G; Candolfi M; Zaldivar V; Zárate S; Ferrari L; Pisera D; Castro MG; Seilicovich A Endocrinology; 2005 Nov; 146(11):4737-44. PubMed ID: 16099864 [TBL] [Abstract][Full Text] [Related]
14. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo. Liu H; Lee ES; Gajdos C; Pearce ST; Chen B; Osipo C; Loweth J; McKian K; De Los Reyes A; Wing L; Jordan VC J Natl Cancer Inst; 2003 Nov; 95(21):1586-97. PubMed ID: 14600091 [TBL] [Abstract][Full Text] [Related]
15. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. Nilsen J; Mor G; Naftolin F J Neurobiol; 2000 Apr; 43(1):64-78. PubMed ID: 10756067 [TBL] [Abstract][Full Text] [Related]
16. Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo. Shim WS; Conaway M; Masamura S; Yue W; Wang JP; Kmar R; Santen RJ Endocrinology; 2000 Jan; 141(1):396-405. PubMed ID: 10614662 [TBL] [Abstract][Full Text] [Related]
17. Apoptotic action of estrogen. Song RX; Santen RJ Apoptosis; 2003 Jan; 8(1):55-60. PubMed ID: 12510152 [TBL] [Abstract][Full Text] [Related]
18. Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Chopin V; Toillon RA; Jouy N; Le Bourhis X Br J Pharmacol; 2002 Jan; 135(1):79-86. PubMed ID: 11786482 [TBL] [Abstract][Full Text] [Related]
19. Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release. Zhang Y; Bhavnani BR BMC Neurosci; 2005 Feb; 6():13. PubMed ID: 15730564 [TBL] [Abstract][Full Text] [Related]
20. Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Liu JJ; Nilsson A; Oredsson S; Badmaev V; Zhao WZ; Duan RD Carcinogenesis; 2002 Dec; 23(12):2087-93. PubMed ID: 12507932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]